RESPIPULMIN DIN 02380803
Health Canada record
| Active ingredient(s) | CLENBUTEROL HYDROCHLORIDE 0.025 MG |
|---|---|
| Dosage form | Syrup |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 15-Sep-2012 |
| Current status date | 15-Sep-2012 |
| Source | Health Canada DPD |
Establishment licence of the holder
Modern Veterinary Therapeutics Inc — licence 3-002686, currently licensed, last inspection rating I (2026-07-08).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLENBUTEROL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00705845 | VENTIPULMIN | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Syrup | CLENBUTEROL HYDROCHLORIDE 0.025 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13064 | 2012-02-28 | Abbreviated New Drug Submission (ANDS) |
International API supply for CLENBUTEROL HYDROCHLORIDE
4 valid EDQM Certificates of Suitability from 4 holders. 1 active FDA Drug Master Files.
Request a quote for RESPIPULMIN